vimarsana.com
Home
Live Updates
BioAegis Therapeutics Completes $22 Million Institutional Sa
BioAegis Therapeutics Completes $22 Million Institutional Sa
BioAegis Therapeutics Completes $22 Million Institutional Sale of Equity in a Non-Brokered Transaction
Fund in Europe leads investment to progress commercialization of breakthrough gelsolin therapy to treat inflammatory and infectious diseases.NORTH BRUNSWICK, N.J., March 22, 2022 (GLOBE NEWSWIRE) -- BioAegis
Related Keywords
Steven Cordovano ,
Kostenloser Wertpapierhandel ,
Christine Lagana ,
Susan Levinson ,
Bioaegis Therapeutics Inc ,
Fund In Europe ,
Aegis Therapeutics ,
Expand Pipeline ,
Meet Manufacturing ,
Chief Executive Officer ,
Bioaegis ,
Herapeutics ,
Ompletes ,
Billion ,
Nstitutional ,
Sale ,
Equity ,
Rokered ,
Transaction ,